Medical-Surgical Nursing · Cancer
Oncological Disorders
On this page 9 sections
In 30 seconds
Cancer is not one disease — it is a family of diseases unified by one underlying failure: cells divide and grow when they should not, in a way that can invade and spread. In normal tissue, cell division is tightly regulated: cells divide when needed, repair their DNA, age, and die on schedule. In cancer, that regulation breaks down, usually because of accumulated somatic mutations (see Chapter 30) in genes that control growth. A single abnormal cell multiplies into a Clone Population of identical cells descended from one ancestor cell Full entry → — identical descendants — and each division may add changes that make it more aggressive. This stepwise process is why cancer risk rises with age.
This topic covers the biology nurses need: the Hallmarks of cancer Shared capabilities acquired by cancer cells Full entry →, the stages of Carcinogenesis Multistep process by which normal cells become cancer Full entry →, the key gene families, benign versus malignant behavior, tumor naming, spread, and Grading How differentiated (normal-looking) the tumor cells are Full entry → and staging. This vocabulary — carcinoma, sarcoma, Metastasis Spread of cancer to distant sites Full entry →, TNM — is the language of every later topic in this chapter.
Why this matters
- Cancer touches every nursing setting — med-surg, oncology, palliative care, and even "non-cancer" units where people with cancer are treated for other problems.
- Biology explains the nursing care. Chemotherapy causes infections because the rapid division that makes tumor cells vulnerable also hits bone marrow; "a small tumor" matters because staging describes spread, not just size.
- Nurses hear the feared question. Understanding what cancer is — and is not — lets nurses give accurate, hopeful-without-false-promise explanations.
- Early detection saves lives. Recognizing warning signs and screening (next topic) depends on how cancers grow and spread.
- Exam value. Benign vs malignant, grading vs staging, and nomenclature are classic exam items.
The college version
Core Concepts
The normal cell cycle and its checkpoints
Cells reproduce through a regulated cycle of growth, DNA copying, and division. Checkpoints — molecular surveillance points — pause the cycle when DNA is damaged, allowing repair or cell death (apoptosis). These safeguards are why most potential cancers never happen. Cancer develops when mutations disable the safeguards: the cell keeps dividing despite damage, ignores stop signals, and survives when it should die.
Hallmarks of cancer
Cancer cells acquire characteristic capabilities: sustained proliferative signaling (growth signals stuck "on"), evading growth suppressors (ignoring stop signals), resisting cell death (blocking apoptosis), replicative immortality (dividing indefinitely), inducing angiogenesis (new blood vessels to feed the tumor), and activating invasion and metastasis (breaking through tissue barriers and spreading). Not every tumor has every hallmark, but the list explains cancer behavior — and why attacking one capability often fails.
Carcinogenesis: initiation, promotion, progression
Cancer develops over years in three overlapping phases. Initiation is the first DNA change — the "spark" from a carcinogen (tobacco smoke, radiation, certain chemicals, some viruses) or from random copying errors. Promotion is the growth of the initiated cell into a visible mass, driven by promoters. Progression is the accumulation of further mutations that make the tumor more aggressive — faster growth, invasion, metastasis. This multistep process is why cancer risk rises with cumulative exposure, and why removing promoters helps even after initiation.
Key gene families: oncogenes, tumor suppressors, DNA repair genes
Three gene families matter most. Oncogenes are normal growth-promoting genes (proto-oncogenes) mutated into "always-on" forms — a gain-of-function change, often from a single mutation. Tumor suppressor genes normally restrain growth; when both copies fail (the "two-hit" pattern: both alleles must fail), the restraint is gone (e.g., RB, TP53). DNA repair genes fix damage; when they fail, mutations accumulate faster throughout the genome. A minority inherit one altered copy (germline), which is why some cancers run in families — but most are somatic, acquired during life.
Benign versus malignant
Benign tumors grow slowly, stay localized, have well-defined borders, and threaten life mainly by pressing on structures. Malignant tumors grow more rapidly, invade surrounding tissue, can seed metastases, and are life-threatening. Malignant cells tend to be less differentiated — more primitive-looking — and this is the basis of grading: well-differentiated (low-grade) tumors resemble their tissue of origin and tend to behave less aggressively; poorly differentiated (high-grade) tumors behave more aggressively. Grading describes the tumor's own character; staging describes how far it has spread.
Naming tumors and how they spread
Names come from the tissue of origin: carcinomas arise from epithelial tissue (skin, organ linings — the most common group); sarcomas arise from connective tissue (bone, muscle, fat); leukemias arise from blood-forming marrow cells and circulate in blood; lymphomas arise from lymphoid tissue; myeloma arises from plasma cells. Metastasis — the hallmark that makes cancer dangerous — occurs by direct extension, lymphatic spread (to lymph nodes), hematogenous spread (through the bloodstream), and transcoelomic seeding (across body cavities). "Metastatic" means the cancer has spread; a metastasis is made of the same cells as the original tumor, not a new disease.
Staging: the TNM system
The most widely used framework describes the tumor itself (T: size and extent), spread to lymph nodes (N), and M (metastasis present or absent). Stage groups (I–IV) guide treatment and prognosis. A stage is a snapshot taken at diagnosis — revised as treatment proceeds or the disease changes.
Common Confusions
| Do not confuse | With | Difference |
|---|---|---|
| Benign | Malignant | Benign stays localized; malignant invades and can metastasize |
| Grading | Staging | Grading = how abnormal the cells look; staging = how far it has spread |
| Carcinoma | Sarcoma | Carcinoma arises from epithelium; sarcoma from connective tissue |
| Metastasis | New primary cancer | A metastasis is the same cell type as the original tumor |
| "Runs in the family" | Inherited | Most mutations are somatic; clustering needs a genetics workup |
| Oncogene | Tumor suppressor gene | Oncogenes push growth "on"; suppressors remove the brakes |
| One mutation | Cancer | Cancer requires multiple accumulated changes over time |
| Stage at diagnosis | Fixed forever | Stage is a snapshot, updated as disease and treatment evolve |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your body's cells have rules: grow when needed, stop when told, and self-destruct when broken. Cancer is a cell that loses the rule book and keeps copying itself anyway — like a jammed photocopier printing after the paper tray is full. Each copy can add new mistakes, so the pile gets bigger and harder to stop.
Worked example
Scenario — making sense of a diagnosis. Rosa, 58, is told she has "stage II adenocarcinoma of the breast with one involved lymph node." The nurse breaks the sentence down: adenocarcinoma tells the cell type (cancer arising from glandular epithelial cells); breast tells the location; stage II combines the T, N, and M findings (tumor size, one node involved, no distant metastasis); one involved lymph node indicates lymphatic spread. She explains the stage is a snapshot from her workup, that grading (how abnormal the cells look) is separate from staging, and that the team uses both to plan care.
When Rosa asks, "Is it the same disease as my sister's lung cancer?" the nurse explains that cancers are named and treated by their tissue of origin — her breast cancer cells remain breast cancer cells even if they travel — and that two people with cancer in the same organ can have very different biology. Rosa leaves able to repeat her own diagnosis in plain words — an informed partner in what follows.
Key takeaways
- Cancer = uncontrolled cell division + ability to invade and spread; it develops over years through initiation, promotion, and progression.
- Hallmarks: sustained growth signaling, evading growth suppression, resisting apoptosis, immortality, angiogenesis, invasion/metastasis.
- Three gene families: oncogenes (always-on growth, gain of function), tumor suppressors (brakes that fail — often "two hits"), DNA repair genes (mutation accumulation).
- Most cancer mutations are somatic (acquired during life); a minority are germline (inherited, run in families).
- Benign vs malignant: localized and non-invasive vs invasive, spreading, life-threatening.
- Grading = tumor differentiation; staging = extent of spread (TNM). Never confuse the two.
- Naming by origin: carcinoma (epithelium), sarcoma (connective tissue), leukemia (blood-forming), lymphoma (lymphoid), myeloma (plasma cells).
- Metastasis routes: direct extension, lymphatic, hematogenous, transcoelomic seeding.
Check yourself
5 review questions from the chapter. Try each one, then open the answer.
List the three phases of carcinogenesis and what happens in each.
Show answer
Initiation — the first DNA change; promotion — growth of the initiated cell into a mass; progression — further mutations that make the tumor more aggressive and invasive.
What is the difference between an Oncogene Growth-promoting gene mutated to "always-on" Full entry → and a Tumor suppressor gene Gene whose normal job is to restrain growth Full entry → — and why do tumor suppressors often need "two hits"?
Show answer
Oncogenes are growth-promoting genes mutated to an always-on state (gain of function, often one mutation). Tumor suppressor genes normally restrain growth; because one working copy can still restrain, both copies usually must be inactivated (loss of function, "two-hit") before the brake fails.
A tumor is described as "well-differentiated, low grade." What does that tell you about its behavior?
Show answer
Low-grade, well-differentiated tumors resemble their tissue of origin and generally grow and spread more slowly than high-grade, poorly differentiated tumors.
What do T, N, and M in the TNM system stand for?
Show answer
T = size and extent of the primary tumor; N = spread to regional lymph nodes; M = presence or absence of distant metastasis.
A person with breast cancer is found to have a liver lesion. Why is it described as metastatic breast cancer rather than new liver cancer?
Show answer
Metastases are made of the same cells as the original tumor. A breast cancer cell that travels to the liver remains a breast cancer cell — so the disease is metastatic breast cancer, treated accordingly.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Clone
- Population of identical cells descended from one ancestor cell
- Hallmarks of cancer
- Shared capabilities acquired by cancer cells
- Carcinogenesis
- Multistep process by which normal cells become cancer
- Oncogene
- Growth-promoting gene mutated to "always-on"
- Tumor suppressor gene
- Gene whose normal job is to restrain growth
- Somatic vs germline mutation
- Acquired in body cells vs inherited in every cell
- Benign tumor
- Localized, non-invasive growth
- Malignant tumor
- Invasive, potentially metastatic growth
- Grading
- How differentiated (normal-looking) the tumor cells are
- Staging (TNM)
- Extent of tumor (T), nodes (N), metastasis (M)
- Metastasis
- Spread of cancer to distant sites
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.